D'Hooge R - Search Results

1

Hyperactivity, neuromotor defects, and impaired learning and memory in a mouse model for metachromatic leukodystrophy.

D'Hooge R, Van Dam D, Franck F, Gieselmann V, De Deyn PP. D'Hooge R, et al. Brain Res. 2001 Jul 13;907(1-2):35-43. doi: 10.1016/s0006-8993(01)02374-5. Brain Res. 2001. PMID: 11430883

2

Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.

Matthes F, Stroobants S, Gerlach D, Wohlenberg C, Wessig C, Fogh J, Gieselmann V, Eckhardt M, D'Hooge R, Matzner U. Matthes F, et al. Hum Mol Genet. 2012 Jun 1;21(11):2599-609. doi: 10.1093/hmg/dds086. Epub 2012 Mar 2. Hum Mol Genet. 2012. PMID: 22388935

3

Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy.

Matzner U, Lüllmann-Rauch R, Stroobants S, Andersson C, Weigelt C, Eistrup C, Fogh J, D'Hooge R, Gieselmann V. Matzner U, et al. Mol Ther. 2009 Apr;17(4):600-6. doi: 10.1038/mt.2008.305. Epub 2009 Jan 27. Mol Ther. 2009. PMID: 19174759 Free PMC article.

4

Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy.

Matzner U, Matthes F, Herbst E, Lüllmann-Rauch R, Callaerts-Vegh Z, D'Hooge R, Weigelt C, Eistrup C, Fogh J, Gieselmann V. Matzner U, et al. Mol Med. 2007 Sep-Oct;13(9-10):471-9. doi: 10.2119/2007-00063.Matzner. Mol Med. 2007. PMID: 17660863 Free PMC article.

5

Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations.

Matzner U, Hartmann D, Lüllmann-Rauch R, Coenen R, Rothert F, Månsson JE, Fredman P, D'Hooge R, De Deyn PP, Gieselmann V. Matzner U, et al. Gene Ther. 2002 Jan;9(1):53-63. doi: 10.1038/sj.gt.3301593. Gene Ther. 2002. PMID: 11850723

6

Metachromatic leukodystrophy: consequences of sulphatide accumulation.

Gieselmann V, Franken S, Klein D, Mansson JE, Sandhoff R, Lüllmann Rauch R, Hartmann D, Saravanan VP, De Deyn PP, D'Hooge R, Van Der Linden AM, Schaeren-Wiemers N. Gieselmann V, et al. Acta Paediatr Suppl. 2003 Dec;92(443):74-9; discussion 45. doi: 10.1111/j.1651-2227.2003.tb00225.x. Acta Paediatr Suppl. 2003. PMID: 14989469

7

Neuromotor alterations and cerebellar deficits in aged arylsulfatase A-deficient transgenic mice.

D'Hooge R, Hartmann D, Manil J, Colin F, Gieselmann V, De Deyn PP. D'Hooge R, et al. Neurosci Lett. 1999 Oct 1;273(2):93-6. doi: 10.1016/s0304-3940(99)00647-3. Neurosci Lett. 1999. PMID: 10505624

8

Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy.

Hess B, Saftig P, Hartmann D, Coenen R, Lüllmann-Rauch R, Goebel HH, Evers M, von Figura K, D'Hooge R, Nagels G, De Deyn P, Peters C, Gieselmann V. Hess B, et al. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14821-6. doi: 10.1073/pnas.93.25.14821. Proc Natl Acad Sci U S A. 1996. PMID: 8962139 Free PMC article.

9

Metachromatic leukodystrophy: molecular genetics and an animal model.

Gieselmann V, Matzner U, Hess B, Lüllmann-Rauch R, Coenen R, Hartmann D, D'Hooge R, DeDeyn P, Nagels G. Gieselmann V, et al. J Inherit Metab Dis. 1998 Aug;21(5):564-74. doi: 10.1023/a:1005471106088. J Inherit Metab Dis. 1998. PMID: 9728336 Review.

10

Restoring the phenotype of fragile X syndrome: insight from the mouse model.

Gantois I, Bakker CE, Reyniers E, Willemsen R, D'Hooge R, De Deyn PP, Oostra BA, Kooy RF. Gantois I, et al. Curr Mol Med. 2001 Sep;1(4):447-55. doi: 10.2174/1566524013363492. Curr Mol Med. 2001. PMID: 11899089 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results